GLP-1s: What 10+ years of experience prescribing them reveals
Date & Time: Tuesday, September 29, 2026 at 2:00 pm ET
Speakers:
Frank Dumont, MD, FACP, Executive Medical Director, Virta Health
Laura Walmsley, Chief Commercial Officer, Virta Health
Catherine Metzgar, PhD, RD, Director of Coaching, Virta Health
Description:
Long before Ozempic became a household name, Virta providers were prescribing and managing GLP-1s in real-world populations. A decade later, that experience tells a different story than what’s often featured in headlines and marketing campaigns, with important implications for employers navigating rising costs, evolving coverage decisions and questions about long-term outcomes.
Join Virta providers and business leaders for a candid, ask-me-anything session addressing the questions benefits professionals are still trying to answer as they evaluate and refine their organizations’ GLP-1 strategies.
Together, they’ll address:
- The clinical reality: How GLP-1s actually work and perform in real-world populations
- The employee experience: What it’s actually like to take, manage and come off GLP-1s
- The strategic and financial implications: What employers should consider when developing a sustainable GLP-1 benefits strategy
